• SSI

    Supplemental Security Income for People with Disabilities: Implications for Medicaid

    States generally must provide Medicaid to poor people with a disability who receive federal Supplemental Security Income (SSI). We describe key characteristics of SSI enrollees, explain the SSI eligibility criteria and eligibility determination process, and consider the implications of changes in the SSI program for Medicaid, including the effects of the COVID-19 pandemic and resulting economic downturn and proposals supported by President Biden that Congress might consider.
  • Tracker

    Medicaid Emergency Authority Tracker: Approved State Actions to Address COVID-19

    Information on approved Medicaid emergency authorities to address the COVID-19 Coronavirus emergency. We include details on Medicaid Disaster Relief State Plan Amendments (SPAs), other Medicaid and CHIP SPAs, and other state-reported administrative actions; Section 1115 Waivers; Section 1135 Waivers; and 1915 (c) Waiver Appendix K strategies.
  • Lowering the Age

    How Might Lowering the Medicare Age Affect Medicaid Enrollees?

    While lowering the Medicare eligibility age based solely on work history to 60 could provide coverage to older adults who are currently uninsured or provide a more affordable option for people with private health insurance coverage, it also could affect Medicaid enrollees in this age range. Some Medicaid enrollees might lose Medicaid coverage when they gain Medicare, and others might become dually eligible for both programs, depending on the details of how it would work.
  • U.S. Territories

    Challenges in the U.S. Territories: COVID-19 and the Medicaid Financing Cliff

    The pandemic has exacerbated long-standing health care challenges faced by Puerto Rico and other U.S. territories as the end of temporary federal Medicaid funding approaches later this year. The expiration of a temporary Medicaid funding at the end of September would result in the loss of over 80% of U.S. territories’ Medicaid funding and could result in reductions in coverage, services, and provider rates
  • Rx Drugs

    How Might Current Federal Drug Pricing Proposals Impact Medicaid?

    How would the Medicaid Rx drug benefit be affected by federal proposals to allow the government to negotiate drug prices in Medicare, limit spread pricing by pharmacy benefit managers, and increase price transparency? We explain in a new Policy Watch. In 2019, Medicaid gross drug spending on prescription drugs was $66 billion; $37 billion was offset by rebates, resulting in $29 billion of net spending that is shared by states and the federal government.
Medicaid Budget Survey

Browse the Latest from KFF

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.